Co-Diagnostics (STU:C97) EV-to-Revenue : -0.54 (As of Jun. 25, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Co-Diagnostics EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Co-Diagnostics's enterprise value is €-3.22 Mil. Co-Diagnostics's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was €5.98 Mil. Therefore, Co-Diagnostics's EV-to-Revenue for today is -0.54.

The historical rank and industry rank for Co-Diagnostics's EV-to-Revenue or its related term are showing as below:

STU:C97' s EV-to-Revenue Range Over the Past 10 Years
Min: -6.41 Med: 6.01 Max: 7105.25
Current: -0.52

During the past 9 years, the highest EV-to-Revenue of Co-Diagnostics was 7105.25. The lowest was -6.41. And the median was 6.01.

STU:C97's EV-to-Revenue is ranked better than
97.09% of 825 companies
in the Medical Devices & Instruments industry
Industry Median: 2.99 vs STU:C97: -0.52

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-25), Co-Diagnostics's stock price is €1.33. Co-Diagnostics's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was €0.20. Therefore, Co-Diagnostics's PS Ratio for today is 6.55.

Co-Diagnostics EV-to-Revenue Historical Data

The historical data trend for Co-Diagnostics's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Co-Diagnostics EV-to-Revenue Chart

Co-Diagnostics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

68.44

2.93

2.17

-0.09

-2.05

Co-Diagnostics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial															-2.39	-4.35	-5.99	-2.05	-1.88

Competitive Comparison of Co-Diagnostics's EV-to-Revenue

For the Medical Devices subindustry, Co-Diagnostics's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Co-Diagnostics's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Co-Diagnostics's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Co-Diagnostics's EV-to-Revenue falls into.

Co-Diagnostics EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Co-Diagnostics's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	-3.218	/	5.978
	=	-0.54

Co-Diagnostics's current Enterprise Value is €-3.22 Mil.
Co-Diagnostics's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €5.98 Mil.

Co-Diagnostics (STU:C97) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Co-Diagnostics's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	1.33	/	0.203
	=	6.55

Co-Diagnostics's share price for today is €1.33.
Co-Diagnostics's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.20.

Co-Diagnostics EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Co-Diagnostics's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Co-Diagnostics (STU:C97) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Co-Diagnostics Inc (STU:C97) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

CODX:USA 0A50:UK

Address

2401 South Foothill Drive, Salt Lake City, UT, USA, 84109

Website

https://www.codiagnostics.com

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV. The company's diagnostics systems enable very rapid, low-cost, sophisticated molecular testing for organisms and genetic diseases by greatly automating historically complex procedures in both the development and administration of tests.

Co-Diagnostics (STU:C97) Headlines

No Headlines